Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing

Measuring total cell-free DNA (cfDNA) or cancer-specific mutations herein has presented as new tools in aiding the treatment of cancer patients. Studies show that total cfDNA bears prognostic value in metastatic colorectal cancer (mCRC) and that measuring cancer-specific mutations could supplement b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Demuth, Christina, Spindler, Karen-Lise Garm, Johansen, Julia S., Pallisgaard, Niels, Nielsen, Dorte, Hogdall, Estrid, Vittrup, Benny, Sorensen, Boe Sandahl
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2018
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6085225/
https://ncbi.nlm.nih.gov/pubmed/30086420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.07.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados